3 Stocks To BUY NOW Before October 2026

We are nearly four years into this bull market that started back in October 2022. This means we have made new highs after new highs calling into question how much more upside is ahead for stocks. If you have the right tools, you can dig deep enough to find real values even in today's market. That's why today I will share three stellar stocks that still have ample upside potential. The key is not just to find cheap stocks. Instead, we want healthy growing companies that are trading for far less than they are worth. That combination is what leads to future outperformance. So, if that appeals to you, let's dive into the three stocks that you should consider adding to your portfolio before October. Let's start with the best value of the bunch. That brings us to the first pick in PBF Energy with a symbol of PBF. This is a US-based oil refiner where they take crude oil and turn into gasoline, diesel, jet fuel, and all other kinds of refined products. And right now is the perfect time to get in this group as the cyclical trends are most certainly your friend leading to surging profits. Before I share the rest of the appealing story for PBF, let me quickly introduce myself. My name is Steve Wrightmeister, but everyone calls me Righty. I've been investing for over 40 years, and today I'm a partner at Wall Street Zen, where we have a wide range of tools to help investors pinpoint the best opportunities. And real quick, if you enjoy stockpicking videos like this one to do yourself a favor and tap that like button. It tells the algorithm to put more content like this in front of you in the future. Back to PBF Energy. And here's the thing about refiners that a lot of investors miss. Their profits aren't really tied to the price of oil, meaning when prices go up or down is not really what moves them. Instead, they are driven by the spread between what they pay for crude and what they can sell the products for. And right now, that spread has been very favorable. And this could be a long-term trend because there has been a great underinvestment in new refineries in the US. Much of that because of stricter regulatory environmental issues. Anyone who has taken Econ 101 knows that this supply demand dynamic is very favorable for higher pricing and higher profits for refiners. In fact, I recently featured this stock as my trade of the week during my weekly live trading session. Now, these Monday free events are focused on the most timely market insights plus my top picks. Now, it's totally free, but you do need to sign up. So, you can do that now to join me this coming Monday. Just go to wall streetzen.com/live. Now, back to the nuts and bolts for PBF. Uh business is good. Like really, really good. The best way to prove that is by sharing that revenue jump 50% quarter [snorts] over quarter. Even with all that growth, shares still trade for a shockingly low forward PE of only four. Yes, only four when the average stock is trading for about 19 or 20 PE. As I shared at the top of the video, if you have the right tools, it's pretty easy to dig up the best stocks. And for me, the best tool is the Zen Raidens Quant, which scores every stock we track against 115 different fundamental, technical, and AI factors. This gets boiled down to an intuitive letter grade of A through F. And yes, the higher the grade, the higher the expected return. In fact, A-rated stocks have beat the S&P 500 by nearly 3 to1 over the years. Gladly PBF is in that elite A-rated territory. That's because after the full 115 factor review, they score in the top 1% of the greater than 4600 stocks that we track. To see what drives that strength, we can further dig into what makes a stock tick via the seven underlying component grades. So, let's take a look at those now. First is financial strength reflecting the health of the balance sheet and top operational metrics which comes in the top 18% of all stocks track. As we keep going we have the ANI factor yet stronger in the top 5% of all stock. Now that doesn't measure how much AI a company uses. Instead it's our application of AI to identify the most timely stocks ready to outperform. Growth comes in the top 3% of all stocks. That's the best category to predict likely more earnings beats ahead. And the true standout is value. It's in the top 1% of all stocks. And this is not just about the forward PE. This is based on 21 different value measures. So from just about every angle, these are very undervalued shares. No stock is without some weakness. In this case, uh safety is the soft spot. But that is often the case for a cyclical business like oil refining. Even still, this is a very compelling investment story. The refining business is set up for a long run of continued growth. On top of that, PBF has a stellar fundamental profile as proven by the Zenraine quant. Lastly, it is shockingly undervalued. Put it all together, you understand why it was my recent trade of the week and why it was the perfect choice to kick off today's video. Next up, we have a stock insiders are buying like crazy. But just one quick ask before we keep going with that stock. And that is if you're finding uh value from this video, then yes, now is the time to hit subscribe and ring the notification bell. That's because I publish datadriven stock analysis like this every single week, and I'd hate for you to miss the next videos. Let's move on to our second pick in Astronics, uh, with the symbol ATRO. You might not be familiar with the name, but you most certainly have flown on a plane with their parts on board. That's because they make the lighting, power outlets, and seat motion systems built into commercial aircraft cabins, plus avionics and radio test equipment for the defense side of the aerospace industry. For years, this was a pretty steady, unexciting supplier. But that story has changed dramatically. Air travel has come roaring back. aircraft projection is ramping up and Astronics is turning that recovery into much much faster earnings growth. So right now, Wall Street experts are projecting 40% earnings growth in the year ahead. That's about three times the pace of industry peers. This is not hollow earnings growth as proven by their remarkable return on equity above 50%. Let's remember Warren Buffett pounds the table about buying stocks. You need them to have ROE above 20%. Estronics blows that number out of the water. Our previous stock in PBF was dirt cheap. Here we are talking more about a GARP stock, meaning growth at a reasonable price. That shows up in their PEG ratio of about one. That is pretty solid value in a market environment where the average stock has a much higher PEG ratio of 1.5. Also helping the value equation is buying it after a hefty round of profit taking from the recent highs. Wall Street coverage here is light, but it is potent. That's because the one analyst on board is Guantanam Kna at TD Cohen. He ranks in the top 11% of all analysts based upon his actual stock picking performance, meaning he knows a thing or two of picking good stocks. He rates Astronics as a strong buy. Even better is his fair value price target, implying nearly 40% upside in the year ahead. Our quant rings data is even more bullish on the outlook for Astronics. Yes, it's A-rated, but that label is reserved for the top 5% of all stocks analyzed. In this case, Extronics is actually in the top 1% pointing to a truly stellar fundamental profile which greatly increases the odds of future share price outperformance. And when you dig into the component grades, you can see exactly what is driving that strength. Sentiment ranks in the top 15% of all stocks. This means the smart money crowd is already circling these shares. Momentum is the top 14% of all stocks. Financials are also excellent in the top 7%. This covers 26 financial measures in total. So not just about ROE. That's super impressive. We got 25 others that are ringing the bell. Growth is the clear headline attraction where Astronics ranks in the top 1% of every stock in our system. This foreshadows more earning speeds ahead. And that is typically one of the best catalyst to create more share price gains. Let's sum up the Astronic story. A formerly sleepy aerospace supplier is suddenly showing serious earnings momentum that should propel shares much, much higher. The deep dive of the Zen rings quant model shines a light on their truly special fundamental profile. And now we get to buy after a nearly 30% dip from the all-time highs. Consider if you are ready to ride these shares to even new heights. Before we get to the final stock in this video, it's a good time to point this out. If you want to stay one step ahead of the market, then join me live every Monday because that's when I share my updated market outlook and trading plan to outperform. It's also when I unveil my trade of the week based upon our proven Zenerings quant model and my greater than 40 years of investing experience. It's a free event, but you do need to register. Just go to wall streetzen.comlive or click the link in the description down below or scan the QR code coming up on your screen. Just pause the video for a moment to sign up. I will be patient and wait for you. Then I look forward to seeing you there on Monday. Okay, let's close out strong with our third and final stock in Corep Therapeutics with a symbol of CO. Corp is a borrow pharmaceutical company built around a single hormone cortisol. You may know it as the stress hormone. Their lead drug, Corlim, treats Cushing syndrome, a condition caused by the body producing, as you guess it, too much cortisol. And in 2026, they got a second headline drug approved for a type of ovarian cancer that's resistant to standard chemotherapy. This isn't a story about a biotech hoping for approval of the drug someday. The new medication is already approved and already being prescribed, and the uptake rate has been very, very impressive. Some investors have taken notice with shares up nicely in recent months, but there is ample reason to believe the upside party is far far from over. That starts at the growth side of the equation where Wall Street analysts expect earnings growth to ramp up 100% a year going forward. These same analysts are lining up with buy and strong buyer recommendations. Even better is that each is expecting 40 to 50% more upside potential to their fair value price targets in the next year alone, much more in the years beyond that. The Zen rings echoes a strong case for these shares. That's because we have yet another A-rated stock and yet another company in the top 1% of all the stocks that we track in our quant database. That is particularly impressive for a biotech stock, which is an industry littered with lowrated companies, many of them burning cash as they hope for a drug approval somewhere down the road. This one is well on its way to healthy profits. The component grades reveals even more to large, starting with the top 20% showing for value. As we keep going down the line, financial strength top 18%, sentiment is top 8%, you know, showing the smart money is already leaning in. Growth comes in the top 5% and the standout grade is the reading for momentum top 3% showing meaning these are timely shares. Often value stocks are not timely. That is not the problem here with Corsep. As you would expect with a small biotech stock, the safety score is below average, meaning that shares are going to be a bit more volatile. But overall, we have an exciting growth story that is ramping up with the second drug approval. This points to outsize growth, right? 100% earnings growth. And yet, shares are shockingly inexpensive. That is usually a great one-two punch point to serious share price gains ahead. So, there's your list. Three stocks with serious upside still ahead for them. The time to explore each is now to see if they deserve a spot in your portfolio. This is also a good time to remind you that Zen rings are updated every single day on the quote pages at wall streetzen.com. Be sure to check the ratings before making any future buy wholesale decisions on these stocks or any others. So, now is a good time to bookmark the site for all your future visits. Okay, now I want to hear from you. Which of these three stocks do you like the most and why? And is there a stock I didn't mention you think belongs in any of my future videos? Drop it all in the comments section below. And if you're looking for more timely stock picks, then I strongly recommend you check out my recent video featuring five standout stocks for this overvalued market.